The $600mn of funding 23andMe raised in its 2021 merger with ... Drugmaker Mallinckrodt, cleansed of its opioid-related legacy, recently merged with rival Endo in a $6.7bn deal.

Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment ...

Albertsons terminated the merger immediately after courts blocked it and sued Kroger, alleging a breach of contract that led to the deal falling apart. Sign up here. The formal termination ended a ...

Her expertise is in personal finance and investing, and real estate. A stock-for-stock merger occurs when shares of one company are traded for another during an acquisition. Shareholders can trade ...

Specialist pharma company Mallinckrodt announced on 26 December that it is to acquire Sucampo Pharmaceuticals for around $1.2 billion. The company’s management are clearly looking to bring cheer ...

Mallinckrodt has finally claimed FDA approval for terlipressin as a treatment for hepatorenal syndrome (HRS), after manufacturing problems scuppered an earlier attempt. Terlipressin – now given ...

Endo + Mallinckrodt Pharmaceuticals! The ~$7B deal will "create a larger and more diversified entity with the scale and resources needed to unlock the full potential of both companies ...

Wataru Endo has had a quiet second season at Liverpool, with the Japanese international hardly getting a look in under Arne Slot. The 32-year-old midfielder joined the Reds last season from VfB ...